Filing Flows › Oscar Health (OSCR) › Q2 2025
Oscar Health (OSCR) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Oscar Health (OSCR) reported revenue of $2.9B for the second quarter 2025 (Q2 2025), +29% from a year earlier and -6% from the quarter before. Operating margin was -8.0%, net loss $228M (8.0% of revenue).
Oscar Health, Q2 2025: revenue $2.9B (+29% year over year), operating margin -8.0%, net loss $228M, operating cash flow $509M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9B | -6% | +29% |
| Operating profit | −$230M | -178% | — |
| Net earnings | −$228M | -183% | — |
| Operating cash flow | $509M | -42% | +2% |
| Free cash flow | $500M | -43% | +2% |
What changed
Revenue was $2.9B in Q2 2025, up 29% year over year and down 6% from the previous quarter.
Operating costs exceeded revenue by $0.23B, an operating margin of -8.0%. Total costs grew 44% against revenue growth of 29%. The fastest-growing cost line was Other operating costs (+49%). The quarter ended with a net loss of $0.23B, after a profit of $0.28B the previous quarter.
Operating cash flow was $0.51B (up 2% year over year). Non-cash charges added back $0.01B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.71B. Capital expenditures of $0.01B left free cash flow of $0.50B.
Questions
What was Oscar Health's revenue in the second quarter 2025?
Oscar Health (OSCR) reported revenue of $2.9B for the second quarter 2025 (Q2 2025), +29% from a year earlier and -6% from the quarter before.
Was Oscar Health profitable in the second quarter 2025?
Operating loss was $230M (-8.0% of revenue) and net loss $228M.
Source: Oscar Health 10-Q on SEC EDGAR.